Three weeks before our scheduled closing date, the buyer submitted a revised purchase price based on alleged diligence findings. How do we determine whether to accept a haircut, restructure the deal, or terminate exclusivity and walk away?
A late-stage purchase price reduction is a standard buyer tactic designed to capitalize on deal fatigue. By week ten of diligence, the buyer assumes you have spent tens of thousands of dollars on legal fees, checked out mentally from operations, and told your family you are selling. They test your resolve by claiming their findings require a valuation haircut.
Take the issue directly into an executive IDS session with your core advisors. Identify the root cause of their requested reduction:
- Is the finding an actual unrecorded balance sheet liability or true EBITDA error, or is it an arbitrary re-interpretation of normal business risk?
- Did your trailing twelve-month earnings decline during the exclusivity window, giving them legitimate mathematical justification for an adjustment?
- Is the buyer dealing with internal financing trouble or cold feet?
If the finding is mathematically legitimate, adjust the line item cleanly or offer a narrow indemnity basket rather than accepting an across-the-board multiple cut. If the finding is an opportunistic attempt to re-trade, you must establish a hard walk-away boundary.
Remind the buyer of the sunken capital they have invested in accounting, legal, and operational diligence. If your business is healthy, your weekly Scorecard numbers are hitting targets, and your leadership team is executing on plan, you hold leverage. Be fully prepared to terminate exclusivity. The willingness to walk away from a bad deal is the only leverage that forces a buyer to stand by their original Letter of Intent.
Category: Valuation & Deal Structure